Clinical Trials Logo

Alzheimer's Type Dementia clinical trials

View clinical trials related to Alzheimer's Type Dementia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03732053 Completed - Cognitive Decline Clinical Trials

The Effectiveness of Global Postural Reeducation on Alzheimer Disease Patients

GPR
Start date: December 5, 2016
Phase: N/A
Study type: Interventional

This research study is developed on an experimental design with randomized controlled intervention were participated 135 subjects with AD including 45 of the control group. It lasted 6 months with pre-post tests (T0-T1) executed before and after six months of treatment. By having in focus the evaluation of GPR therapy effects on cognitive, proprioceptive, depressive, autonomy, gait and life quality of the above mentioned subjects.

NCT ID: NCT01972204 Completed - Clinical trials for Alzheimer's Type Dementia

Intensive Instruction on the Use of Aricept

Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the influence of the instruction on the use of Aricept with educational brochure on the 48-week medication persistence and to assess the reasons for discontinuation.

NCT ID: NCT01539031 Completed - Clinical trials for Alzheimer's Type Dementia

Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease

Start date: March 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare 23 mg donepezil sustained release to the currently marketed formulation of 10 mg donepezil immediate release in patients with severe Alzheimer's disease.

NCT ID: NCT01404169 Completed - Clinical trials for Alzheimer's Type Dementia

A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease

Start date: September 2011
Phase: Phase 3
Study type: Interventional

The objective is to demonstrate that donepezil hydrochloride 10 mg/day has superior efficacy compared with placebo in cognitive function in Chinese subjects with severe Alzheimer's Disease.

NCT ID: NCT01276353 Completed - Clinical trials for Alzheimer's Type Dementia

A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia

Start date: January 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare 23 mg donepezil sustained release (SR) to the currently marketed formulation of 10 mg donepezil immediate release (IR) in patients with severe Alzheimer's disease.